Filing Details

Accession Number:
0001077183-21-000249
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-26 16:14:57
Reporting Period:
2021-11-23
Accepted Time:
2021-11-26 16:14:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1077183 Neogenomics Inc NEO Services-Testing Laboratories (8734) 742897368
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1849414 Matthew Douglas Brown 12701 Commonwealth Drive
Suite 9
Fort Myers FL 33913
Chief Strategy Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-11-23 33,333 $37.19 78,311 No 4 S Direct
Common Stock Disposition 2021-11-24 33,333 $36.84 44,978 No 4 S Direct
Common Stock Disposition 2021-11-26 33,334 $36.85 11,644 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $28.33 2027-03-02 45,017 45,017 Direct
Common Stock Stock Option (Right to Buy) $53.17 2028-03-02 26,378 26,378 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2027-03-02 45,017 45,017 Direct
2028-03-02 26,378 26,378 Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. On March 2, 2020, Mr. Brown was granted 45,017 stock options. These options vest ratably over the first four anniversary dates of the grant date.
  3. On March 2, 2021, Mr. Brown was granted 26,378 stock options. These options vest ratably over the first four anniversary dates of the grant date.